Morgan Stanley
-
-
-
-
-
-
-
Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel
-
-
-
-
-
-
-
Morgan Stanley Reiterates Equalweight Rating on Gilead Sciences (GILD)
-
-
-
-
-
-
-
Gilead Sciences (GILD) Has an 80% Chance of Trading Higher on this Catalyst - Morgan Stanley
-
-
-
-
-
-
-
Court Reverses Gilead Sciences (GILD) Car-T Overhang, Morgan Stanley Sees 3 Positive Implications
-
-
-
-
-
-
-
Tech leads crisis-driven M&A boom with $350 billion deal rush
-
-
-
-
-
-
-
Pre-Open Movers 04/17: (AMC) (TROX) (MRNA) Higher; (CUTR) (NLS) (CHWY) Lower (more...)
-
-
-
-
-
-
-
Gilead Sciences (GILD) PT Lowered to $82 at Morgan Stanley
-
224,964 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

